drugset / Trial / NCT03769298

CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

NCT03769298

NaSingle-groupOpen-labelTreatment

Summary

This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 20 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.

Timeline

Start
2019-02-27
Primary completion
2026-12
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.75 mg Oral
Subject Tacrolimus Small molecule 1 mg Oral
Subject Tacrolimus Small molecule 4 mg Oral

Indications

No indication recorded.